Description
This specialized co-culture kit facilitates the reliable in vitro evaluation of cellular immunotherapies by maintaining the viability of both colorectal cancer organoids and various primary immune cells (e.g., TILs, CIKs). By overcoming the challenge of incompatible culture conditions, it provides a physiologically relevant model to study complex tumor-immune microenvironment interactions, accelerating the development of novel cancer treatments.